Clinical Trial Update: Safety, Pharmacokinetics, and Pharmacodynamics of ARC1779 in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety, pharmacokinetics, and pharmacodynamics of ARC1779 in healthy volunteers. The study is sponsored by Archemix Corp and relates to…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombosis

Drugs mentioned

• ARC1779

Snippet

Sponsor: Archemix Corp. | Conditions: Thrombosis | Phase 1 | Status: COMPLETED